Allogene Therapeutics Inc

Allogene Therapeutics Inc

ALLO

Market Cap$258.1M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Allogene Therapeutics IncAllogene Therapeutics Inc-1--65%-1.10.1
$-0.08

Current Fair Value

107.1% downside

Overvalued by 107.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$258.10 Million
Enterprise Value$271.98 Million
Dividend Yield$0 (0%)
Earnings per Share$-1.32
Beta0.31
Outstanding Shares215,359,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-1.01
PEG12.43
Price to Sales-1.13
Price to Book Ratio1.13
Enterprise Value to Revenue-12362.53
Enterprise Value to EBIT-1.06
Enterprise Value to Net Income-2
Total Debt to Enterprise0.21
Debt to Equity0.15

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Allogene Therapeutics Inc